GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Atrys Health SA (XMAD:ATRY) » Definitions » Piotroski F-Score

Atrys Health (XMAD:ATRY) Piotroski F-Score : 3 (As of Jun. 01, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Atrys Health Piotroski F-Score?

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Atrys Health has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Atrys Health's Piotroski F-Score or its related term are showing as below:

XMAD:ATRY' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 3   Max: 5
Current: 3

During the past 8 years, the highest Piotroski F-Score of Atrys Health was 5. The lowest was 2. And the median was 3.


Atrys Health Piotroski F-Score Historical Data

The historical data trend for Atrys Health's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Atrys Health Piotroski F-Score Chart

Atrys Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial 3.00 2.00 5.00 3.00 3.00

Atrys Health Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 - 3.00 - 3.00

Competitive Comparison of Atrys Health's Piotroski F-Score

For the Biotechnology subindustry, Atrys Health's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Atrys Health's Piotroski F-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Atrys Health's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Atrys Health's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was €-45.6 Mil.
Cash Flow from Operations was €-1.1 Mil.
Revenue was €201.6 Mil.
Gross Profit was €141.8 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was (704.048 + 629.001) / 2 = €666.5245 Mil.
Total Assets at the begining of this year (Dec22) was €704.0 Mil.
Long-Term Debt & Capital Lease Obligation was €189.7 Mil.
Total Current Assets was €100.9 Mil.
Total Current Liabilities was €103.6 Mil.
Net Income was €-23.1 Mil.

Revenue was €158.4 Mil.
Gross Profit was €126.0 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was (564.287 + 704.048) / 2 = €634.1675 Mil.
Total Assets at the begining of last year (Dec21) was €564.3 Mil.
Long-Term Debt & Capital Lease Obligation was €210.5 Mil.
Total Current Assets was €101.9 Mil.
Total Current Liabilities was €100.6 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Atrys Health's current Net Income (TTM) was -45.6. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Atrys Health's current Cash Flow from Operations (TTM) was -1.1. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-45.59/704.048
=-0.06475411

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-23.147/564.287
=-0.04101991

Atrys Health's return on assets of this year was -0.06475411. Atrys Health's return on assets of last year was -0.04101991. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Atrys Health's current Net Income (TTM) was -45.6. Atrys Health's current Cash Flow from Operations (TTM) was -1.1. ==> -1.1 > -45.6 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=189.689/666.5245
=0.28459419

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=210.481/634.1675
=0.33190127

Atrys Health's gearing of this year was 0.28459419. Atrys Health's gearing of last year was 0.33190127. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=100.87/103.642
=0.97325409

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=101.872/100.563
=1.01301672

Atrys Health's current ratio of this year was 0.97325409. Atrys Health's current ratio of last year was 1.01301672. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Atrys Health's number of shares in issue this year was 77.265. Atrys Health's number of shares in issue last year was 70.472. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=141.77/201.569
=0.70333236

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=126/158.366
=0.79562532

Atrys Health's gross margin of this year was 0.70333236. Atrys Health's gross margin of last year was 0.79562532. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=201.569/704.048
=0.28630008

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=158.366/564.287
=0.28064797

Atrys Health's asset turnover of this year was 0.28630008. Atrys Health's asset turnover of last year was 0.28064797. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+0+0+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Atrys Health has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Atrys Health  (XMAD:ATRY) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Atrys Health Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Atrys Health's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Atrys Health (XMAD:ATRY) Business Description

Traded in Other Exchanges
Address
c/ Provença, 392 planta baja, Barcelona, ESP, 08025
Atrys Health SA is a Spain based biomedical company which focuses on developing tools for the diagnosis and treatment of cancer and precancerous conditions. It offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics. The company uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology.

Atrys Health (XMAD:ATRY) Headlines

No Headlines